MICALLEF JACOB VINCENT (Chief Scientific Officer) purchased 20.7% of their position (32.34K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $71.9K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/20/2022ACC: 0001477932-22-009423
Officer· Chief Scientific Officer
+32.34K
Net shares
Net buyer
$71.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
32.34K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.34K
Price / share
$1.96
Trade value
$14.38K
% of position
4.7%
—
156.05K→163.39K
Common Stock
Direct
Shares
+25K
Price / share
$2.30
Trade value
$57.50K
% of position
15.3%
—
163.39K→188.39K
Total
Net shares
+32.34K
Net value
$71.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +7.34K | $1.96 | $14.38K | 4.7% | 156.05K | 163.39K |
| Common Stock Direct | — | P · Purchase | +25K | $2.30 | $57.50K | 15.3% | 163.39K | 188.39K |
| Total | +32.34K | $71.88K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned38.11K
Common Stock
IndirectShares owned35K
Total
73.11K indirect73.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 38.11K | Indirect |
| Common Stock | 35K | Indirect |
| Total | 73.11K | 73.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported